Publicaciones etiquetadas ‘Recursos’

Recursos

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer.

Related Articles A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer. Clin Cancer Res. 2018 01 15;24(2):316-325 Authors: Grothey A, Strosberg JR, Renfro LA, Hurwitz HI, Marshall JL, Safran H, Guarino MJ, Kim GP, Hecht JR, Weil SC, Heyburn J, Wang W, Schweizer C, O’Shannessy DJ, Diaz LA Abstract Purpose: The purpose of this study was to evaluate the safety and efficacy of ontuxizumab (MORAb-004), a monoclonal antibody that interferes with endosialin (tumor endothelial marker-1) function, in patients with chemorefractory metastatic colorectal…
Origen: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer. – PubMed

Leer más

Recursos

[New S3 guideline for esophageal cancer : Important surgical aspects].

Related Articles [New S3 guideline for esophageal cancer : Important surgical aspects]. Chirurg. 2016 Oct;87(10):865-72 Authors: Hölscher AH, Stahl M, Messmann H, Stuschke M, Meyer HJ, Porschen R Abstract The current German S3 guideline represents the recommendations for the diagnosis and therapy of squamous cell carcinomas and adenocarcinomas of the esophagus based on evidence from the literature and interdisciplinary expert consensus. Esophagogastroscopy with biopsy, endosonography, and spiral CT scan of the neck, thorax, and abdomen are decisive in staging and the choice of therapy. For a curative approach, surgery, especially transthoracic esophagectomy and gastric pull-up, is the most important therapeutic option,…
Origen: [New S3 guideline for esophageal cancer : Important surgical aspects]. – PubMed

Leer más

Recursos

[The role of end-of-life palliative sedation: medical and ethical aspects – Review].

Related Articles [The role of end-of-life palliative sedation: medical and ethical aspects – Review]. Rev Bras Anestesiol. 2019 Jan – Feb;69(1):72-77 Authors: Menezes MS, Figueiredo MDGMDCA Abstract BACKGROUND AND OBJECTIVE: Palliative sedation is a medical procedure that has been used for more than 25 years to relieve refractory symptoms not responsive to any previous treatment in patients with no possibility of cure and near the end of life. Many uncertainties persist on the theme regarding definition, indications, decision making, most appropriate place to perform the procedure, most used drugs, need for monitoring, fluids and nutritional support, and possible ethical dilemmas.…
Origen: [The role of end-of-life palliative sedation: medical and ethical aspects – Review]. – PubMed

Leer más

Recursos

To explore the relationship between the use of midazolam and cessation of oral intake in the terminal phase of hospice inpatients: A retrospective case note review: Does midazolam affect oral intake in the dying?

Related Articles To explore the relationship between the use of midazolam and cessation of oral intake in the terminal phase of hospice inpatients: A retrospective case note review: Does midazolam affect oral intake in the dying? Palliat Med. 2017 Jan;31(1):89-92 Authors: Giles A, Sykes N Abstract BACKGROUND: Sedative drugs are used to improve comfort in dying patients but have been accused of shortening survival by reducing patients’ ability to maintain nutrition and hydration. However, as part of the dying process, patients in the last days of life often have impaired conscious levels and an inability to maintain oral intake. AIM:…
Origen: To explore the relationship between the use of midazolam and cessation of oral intake in the terminal phase of hospice inpatients: A retrospective case note review: Does midazolam affect oral intake in the dying? – PubMed

Leer más